PT - JOURNAL ARTICLE AU - Lamichhane, Jyoti AU - Upreti, Milan AU - Nepal, Krishus AU - Upadhyay, Bishnu Prasad AU - Maharjan, Urusha AU - Shrestha, Ram Krishna AU - Chapagain, Ram Hari AU - Banjara, Megha Raj AU - Thapa Shrestha, Upendra TI - Burden of Human Metapneumovirus-associated pneumonia among children attending a Tertiary Care Hospital, Kathmandu AID - 10.1101/2022.09.04.22279574 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.04.22279574 4099 - http://medrxiv.org/content/early/2022/09/09/2022.09.04.22279574.short 4100 - http://medrxiv.org/content/early/2022/09/09/2022.09.04.22279574.full AB - Background Acute Respiratory Tract Infection (ARI) is one of the most common causes of mortality and morbidity worldwide. Every year millions of children suffer from viral Respiratory Tract Infections (RTIs) ranging from mild to severe illnesses. Human Metapneumovirus (HMPV) is among the most frequent viruses responsible for RTIs. However, HMPV infections and their severity among children have not been explored yet in Nepal. Therefore, the study aimed to determine the incidence of HMPV among children attending Kanti Children’s Hospital and assess the clinical characteristics of the infections as well as find out the co-infections.Methods A hospital-based cross-sectional study was carried out from September 2018 to April 2019. A total of 105 throat swabs were collected from children clinically suspected of ARIs. The collected samples were tested for the presence of HMPV RNA by Multiplex Real-time PCR (RT-PCR) assay.Results The incidence of HMPV in children in Kanti Children’s Hospital was found to be 13.3%. The HMPV was more prevalent in the age group less than three years (21.8%) which was found to be statistically significant (p - 0.038). Cough and fever were the most common clinical features present in all children infected with HMPV followed by rhinorrhea, sore throat, and wheezing. HMPV positive children were diagnosed with pneumonia (42.9%), bronchiolitis (28.5%), upper respiratory tract infections (14.3%) and asthma (14.3%). The incidence of HMPV was high in late winter (14.3%) followed by early spring (13.5%).Conclusion This study provides the baseline information on HMPV and associated co-infection with other respiratory viruses for differential diagnosis and rational use of antibiotics in clinical management.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study didn't receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committees, Kanti Children's Hospital, Kathmandu, NepalI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the corresponding author.ARIAcute Respiratory Tract InfectionCDCCenter for Disease Control and PreventioncDNAComplimentary DNACOPDChronic Obstructive Pulmonary DiseaseCtCycle threshold valueDNADeoxyribonucleic acidHMPVHuman MetapneumovirusNCNegative controlPCPositive ControlRTIsRespiratory Tract InfectionsRNARibonucleic acidRSVRespiratory Syncytial VirusRT-PCRReverse Transcriptase Polymerase Chain ReactionURTIsUpper Respiratory Tract InfectionsVTMViral Transportation Media.